JP2014502143A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014502143A5 JP2014502143A5 JP2013532945A JP2013532945A JP2014502143A5 JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5 JP 2013532945 A JP2013532945 A JP 2013532945A JP 2013532945 A JP2013532945 A JP 2013532945A JP 2014502143 A5 JP2014502143 A5 JP 2014502143A5
- Authority
- JP
- Japan
- Prior art keywords
- rsv
- polypeptide
- seq
- vlp
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39059110P | 2010-10-06 | 2010-10-06 | |
| US61/390,591 | 2010-10-06 | ||
| PCT/US2011/055113 WO2012048115A2 (en) | 2010-10-06 | 2011-10-06 | Polypeptides and their use in treating and limiting respiratory syncytial virus infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014502143A JP2014502143A (ja) | 2014-01-30 |
| JP2014502143A5 true JP2014502143A5 (enExample) | 2014-10-30 |
| JP6023061B2 JP6023061B2 (ja) | 2016-11-09 |
Family
ID=44993163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013532945A Expired - Fee Related JP6023061B2 (ja) | 2010-10-06 | 2011-10-06 | ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9718862B2 (enExample) |
| EP (1) | EP2625194B1 (enExample) |
| JP (1) | JP6023061B2 (enExample) |
| CN (1) | CN103282378B (enExample) |
| AU (1) | AU2011311946B8 (enExample) |
| CA (1) | CA2813752A1 (enExample) |
| WO (1) | WO2012048115A2 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6023061B2 (ja) | 2010-10-06 | 2016-11-09 | ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーションＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｗａｓｈｉｎｇｔｏｎ Ｔｈｒｏｕｇｈ Ｉｔｓ Ｃｅｎｔｅｒ Ｆｏｒ Ｃｏｍｍｅｒｃｉａｌｉｚａｔｉｏｎ | ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用 |
| US9701720B2 (en) | 2012-04-05 | 2017-07-11 | University Of Washington Through Its Center For Commercialization | Epitope-scaffold immunogens against respiratory syncytial virus (RSV) |
| WO2017081082A2 (en) * | 2015-11-09 | 2017-05-18 | Curevac Ag | Optimized nucleic acid molecules |
| SG11201908999QA (en) * | 2017-04-04 | 2019-10-30 | Univ Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| CN110891592B (zh) | 2017-06-14 | 2024-08-13 | 维罗米蒂克斯股份公司 | 用于保护免受呼吸道合胞病毒的环状肽 |
| EP3897708A1 (en) | 2018-12-20 | 2021-10-27 | Virometix AG | Lipopeptide building blocks and synthetic virus-like particles |
| CN110853704B (zh) * | 2019-11-11 | 2020-11-06 | 腾讯科技（深圳）有限公司 | 蛋白质数据获取方法、装置、计算机设备及存储介质 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5334394A (en) | 1990-06-22 | 1994-08-02 | The Regents Of The University Of California | Human immunodeficiency virus decoy |
| US5770380A (en) | 1996-09-13 | 1998-06-23 | University Of Pittsburgh | Synthetic antibody mimics--multiple peptide loops attached to a molecular scaffold |
| US7138103B2 (en) * | 1998-06-22 | 2006-11-21 | Immunomedics, Inc. | Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| PL192016B1 (pl) | 1998-11-30 | 2006-08-31 | Cytos Biotechnology Ag | Kompozycja, sposób wytwarzania sztucznego, uporządkowanego i powtarzalnego układu antygenu, zastosowanie kompozycji oraz kompozycja szczepionki |
| US6955717B2 (en) | 2001-05-01 | 2005-10-18 | Medimmune Inc. | Crystals and structure of Synagis Fab |
| US7097841B2 (en) | 2002-05-10 | 2006-08-29 | New Century Pharmaceuticals, Inc. | Ferritin fusion proteins for use in vaccines and other applications |
| AU2005286770A1 (en) | 2004-09-21 | 2006-03-30 | Medimmune, Llc | Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| US20100068217A1 (en) | 2006-08-25 | 2010-03-18 | Kwong Peter D | Epitope-transplant scaffolds and their use |
| KR101617895B1 (ko) | 2007-12-24 | 2016-05-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 재조합 ｒｓｖ 항원 |
| US20120034254A1 (en) | 2008-02-07 | 2012-02-09 | Kwong Peter D | Antigenic cloaking and its use |
| US8580270B2 (en) | 2008-09-30 | 2013-11-12 | University Of Massachusetts | Respiratory synctial virus (RSV) sequences for protein expression and vaccines |
| WO2011050168A2 (en) | 2009-10-21 | 2011-04-28 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic | Rsv immunogens, antibodies and compositions thereof |
| JP6023061B2 (ja) | 2010-10-06 | 2016-11-09 | ザ ユニバーシティ オブ ワシントン スルー イッツ センター フォー コマーシャライゼーションＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｗａｓｈｉｎｇｔｏｎ Ｔｈｒｏｕｇｈ Ｉｔｓ Ｃｅｎｔｅｒ Ｆｏｒ Ｃｏｍｍｅｒｃｉａｌｉｚａｔｉｏｎ | ポリペプチド、ならびに呼吸器多核体ウイルス感染症の治療および制限における該ポリペプチドの使用 |
| US9701720B2 (en) | 2012-04-05 | 2017-07-11 | University Of Washington Through Its Center For Commercialization | Epitope-scaffold immunogens against respiratory syncytial virus (RSV) |
-
2011
- 2011-10-06 JP JP2013532945A patent/JP6023061B2/ja not_active Expired - Fee Related
- 2011-10-06 EP EP11773937.5A patent/EP2625194B1/en not_active Not-in-force
- 2011-10-06 WO PCT/US2011/055113 patent/WO2012048115A2/en not_active Ceased
- 2011-10-06 US US13/878,122 patent/US9718862B2/en not_active Expired - Fee Related
- 2011-10-06 AU AU2011311946A patent/AU2011311946B8/en not_active Ceased
- 2011-10-06 CA CA2813752A patent/CA2813752A1/en active Pending
- 2011-10-06 CN CN201180058569.8A patent/CN103282378B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12239699B2 (en) | Immunogen for broad-spectrum influenza vaccine and application thereof | |
| JP6949027B2 (ja) | ジカウイルスワクチン | |
| CN103239734B (zh) | 用于预防和/或治疗呼吸道合胞病毒感染的疫苗 | |
| CN113666990B (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| JP2010166921A5 (enExample) | ||
| Jiang et al. | Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy | |
| CN104293741A (zh) | 一种呼吸道合胞病毒病毒样颗粒疫苗及其制备方法和应用 | |
| Madhukalya et al. | Nipah virus: pathogenesis, genome, diagnosis, and treatment | |
| WO2023023940A1 (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| CN118994328A (zh) | 呼吸道合胞病毒疫苗及其制备方法和应用 | |
| JP2016528176A5 (enExample) | ||
| CN102127554B (zh) | 一种日本脑炎颗粒疫苗及其制备方法和应用 | |
| JP2012517239A5 (enExample) | ||
| Alturaiki et al. | The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2 | |
| CN103316357B (zh) | 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法 | |
| RU2018103757A (ru) | Рекомбинантные вирусоподобные частицы (vlp) с использованием протеина группового антигена (gag) вируса бычьего иммунодефицита | |
| CN102813920A (zh) | 一种疫苗佐剂 | |
| CN111514287A (zh) | 甲型流感通用型dna疫苗及其制备方法和应用 | |
| JP2022513438A5 (enExample) | ||
| Albalaty et al. | SARS-CoV-2 vaccines from A to Z: A review of the current challenges | |
| WO2019129254A1 (zh) | 一种流感病毒抗体的新应用 | |
| CN102943087A (zh) | 兔出血症病毒新型亚单位疫苗及其制备方法 | |
| Tsujimura et al. | Allergy vaccines using a mycobacterium-secreted antigen, Ag85B, and an IL-4 antagonist | |
| CN105218679A (zh) | 人偏肺病毒多表位抗原及其应用 | |
| WO2022000845A1 (zh) | 一种预防SARS-CoV-2的重组蛋白疫苗及其制备方法 |